[v] Alba, M., Rabinowitz, D., & Meyer, L., et al
Therapeutic Indications and Dosing Protocols Among GLP-1 receptor agonists approved for weight management, liraglutide (SAXENDA) is one of the earliest agents to receive authorization from both the FDA and EMA
weight regain commonly occurs after discontinuation, suggesting long-term management may be necessary
73 GunnarsdottirS.RuckiM.ElfarraA
Therefore, in the current clinical context, postbiotics may be more realistically positioned not as primary weight-loss interventions but rather as complementary nutritional strategies to be implemented following the discontinuation of GLP-1 receptor agonist therapy ( Microbiota signatures of response and non-response to GLP-1 RA therapy Interindividual variability in therapeutic response to GLP-1 RAs has sparked growing interest in the role of the gut microbiota in determining drug efficacy
Key Takeaways Standard lipo c dosage is 1ml intramuscularly once weekly, delivering 2550mg methionine, 2550mg inositol, and 50100mg choline per injection